UpHealth Inc. (UPH) Director Owns Stock Worth $800.0

UpHealth Inc. (NYSE:UPH) finished Wednesday with an addition of $0.04 to close at $1.83, an upside of 2.23 percent. An average of 4,217,620 shares of common stock have been traded in the last five days. There was a gain of $0.1400 in the past week. The last 20 days have seen an average of 2,546,700 shares traded, while the 50-day average volume stands at 1,236,168.

UPH stock has decreased by -52.59% in the last month. The company shares reached their 1-month lowest point of $1.6100 on 10/06/21. With the stock rallying to its 52-week high on 01/13/21, shares of the company touched a low of $1.61 and a high of $12.12 in 52 weeks. In spite of this, the price is down -84.90% from the 52-week high.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Insider Transactions

43 days have passed since UpHealth Inc. (UPH) last reported insider trading activity. Katz Avi S, who is Director, most recently acquired $800 shares at $5.15 per share on Sep 01.

Valuation Metrics

UpHealth Inc. (UPH) has a trailing price-to-earnings (P/E) ratio of 23.70 for the broader industry and 32.30 for the sector. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 4.76, the price-to-book (PB) ratio at 0.30.

The quick ratio of UpHealth Inc. for the three months ended June 29 was 0.90, and the current ratio was 1.00, indicating that the company is not able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.17 and a total debt to equity ratio of 0.25 for the quarter ending June 29.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, UpHealth Inc.’s return on assets was -11.40%. For the broader industry, ROE averaged 9.65 over the past year.

Earnings Surprise

The company posted a net income of $31.88 million in the quarter, while revenues of $0.0 were grew 100.0%. The analyst consensus anticipated UpHealth Inc.’s latest quarter earnings to come in at -$0.11 per share, but it turned out to be -$0.38, a -245.50% surprise. For the quarter, EBITDA amounted to -$35.55 million. Shareholders own equity worth $117.61 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at UpHealth Inc. (UPH) price momentum. RSI 9-day as of the close on 13 October was 17.54%, suggesting the stock is oversold, with historical volatility in this time frame at 226.89%.

As of today, UPH’s price is $1.7520 +8.28% or $0.1400 from its 5-day moving average. UPH is currently trading -52.71% lower than its 20-day SMA and -81.83% lower than its 100-day SMA. However, the stock’s current price level is -70.86% below the SMA50 and -84.21% below the SMA200.

The stochastic %K and %D were 7.15% and 5.64%, respectively, and the average true range (ATR) was 0.2515. With the 14-day stochastic at 9.48% and the average true range at 0.2737, the RSI (14) stands at 18.90%. The stock has reached -0.1933 on the 9-day MACD Oscillator while the 14-day reading was at -0.7036.

Analyst Ratings

Oppenheimer launched coverage on UpHealth Inc. (NYSE: UPH) in its analyst report released on July 22, 2021. The firm assigned the stock a an Outperform rating.The consensus rating for UpHealth Inc. (UPH) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell UPH, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 3 others rate it as a “buy”.

What is UPH’s price target for the next 12 months?

Analysts predict a range of price targets between $11.50 and $14.00, with a median target of $12.00. Taking a look at these predictions, the average price target given by analysts for UpHealth Inc. (UPH) stock is $12.50.


Please enter your comment!
Please enter your name here


Hot Topics

Related Videos

Related Videos

Related Articles



Download Free eBook For



100% free. stop anytime no spam